Something to Wear Tonight: The OTC-to-Custom Device

This is More Than Teeth. The newsletter that helps dental sleep professionals get 1% better every week. Subscribe here.

Good Morning.

Last week, we walked the airway from front to back, from the nasal valve to the tongue base, and matched a low-cost measure to each obstruction site. That's the foundation. But your third-tier patient (diagnosed with OSA, said “no” to CPAP or custom appliance, still months of saving away) usually wants something more concrete. They want something to wear tonight.

Here's the trap. The device that's easiest to hand them is a drugstore or direct-to-consumer mouthguard, and the good ones are cleared for snoring, not apnea. Hand it over as "treatment," and you've stepped off the defensible path. Refuse to engage, and the patient buys one anyway, unsupervised.

This is Part 2 of a three-part series. Part 1 gave you the pathway. Part 2 gives you the device tier: what you can legitimately offer while the patient saves for the custom appliance, and how to bridge from an over-the-counter (OTC) device to a custom one without overpromising. Part 3 builds an airway-training tool from scratch. Today, two mouthguards that look alike and are legally worlds apart.

The 30-Second Version

• The "wearable" tier splits sharply: OTC snoring devices vs. custom, titratable OSA appliances, and their FDA clearances are not the same thing.

• Somnofit-S (Oscimed, sold in the US as the SnoreLessNow Anti-Snore Mouth Guard+) and Zyppah are both FDA-cleared for snoring only, not OSA. Treat either one as a tolerance-and-comfort trial, not therapy.

• The 2015 AASM/AADSM guideline (Ramar et al.) is explicit: for OSA, a qualified dentist should use a custom, titratable appliance over non-custom devices. The custom EMA is the therapeutic endpoint.

• Boil-and-bite/thermoplastic devices underperform: in a head-to-head RCT (Vanderveken et al., 2008), only the custom device reduced AHI; the thermoplastic failed in roughly 69% of cases, mostly due to poor overnight retention.

• The defensible on-ramp: a short, low-cost OTC trial to test tolerance and relieve snoring → escalate to a custom EMA (the OSA-cleared, titratable therapy) → re-test with HSAT at 8–12 weeks. Snoring gone ≠ apnea controlled.

6-minute read.

First, the frame that keeps you safe

Same spine as Part 1, one sentence longer this week: an OTC device cleared for snoring is not a treatment for OSA. It can make a patient quieter and more comfortable, and it can tell you whether jaw advancement is tolerable. However, OSA itself is managed with the patient's physician, and when a device is planned, a custom, titratable appliance is prescribed and adjusted by a qualified dentist. Everything below is a bridge to that care, not a substitute. And prove it objectively: re-test with an HSAT at 8–12 weeks before calling anything controlled.

Two "wearables," two very different clearances

Your patient sees "mouthguard" and assumes it's a single category. It isn't, and the difference is the whole issue.

An OTC mandibular advancement device, such as the Somnofit-S or Zyppah, is cleared to reduce snoring. A custom titratable mandibular advancement device, such as the Myerson EMA, is cleared for the treatment of obstructive sleep apnea. Same basic idea (hold the mandible forward, open the retroglossal space), but the regulatory clearance, the fit, and the evidence behind them are not equivalent.

The clearance is the line that keeps you safe. Recommending a snoring-cleared device as OSA "treatment" is the misstep that turns a helpful bridge into a liability. So position the OTC device honestly: as a way to quiet snoring and to test whether advancement is tolerable while the patient works toward the appliance that's actually cleared for their diagnosis.

The OTC tier: Zyppah, Somnofit-S, and the honest read

Zyppah is the name most of your patients will already recognize. It's a boil-and-bite hybrid device that pairs a mandibular tray with an elastic tongue-stabilization strap, self-fitted at home and sold directly to consumers. The FDA cleared it in 2019 (K182312) to reduce snoring in adults, and the label states outright that the device does not treat OSA.

Somnofit-S is a second example worth knowing, a Swiss-made (Oscimed) thermoform-fit device sold in the US as the SnoreLessNow Anti-Snore Mouth Guard+. It's FDA-cleared for snoring only, the same ceiling as Zyppah. There's a small manufacturer-associated efficacy study floating around for it; treat that as marketing, not evidence, until something independent comes along.

Why the caution is earned. Thermoplastic devices underperform as a class. In the Vanderveken (2008) head-to-head RCT, only the custom appliance reduced AHI; the thermoplastic device had a 69% total failure rate, largely because it wouldn't stay in overnight. A device that feels fine can still do very little to help with apnea.

So use them for what they're actually good at: a low-cost, low-commitment way to (1) quiet the snoring tonight and (2) find out whether mandibular advancement is comfortable and worth pursuing, before anyone spends on custom.

The on-ramp: from OTC to a custom EMA, defensibly

Four steps turn a drugstore mouthguard into a defensible pathway rather than a shortcut.

1. Check if the patient is a good candidate. This is suitable for someone who doesn't want to use CPAP, is saving for a custom device, and can handle having something in their mouth. It's not for those with severe sleep apnea, as they need to talk to a doctor instead of trying this on their own.

2. Try an over-the-counter (OTC) device as a test. See if moving the jaw forward helps with symptoms and if it's comfortable to wear overnight. Check for any jaw or bite issues. This is a low-cost way to see if jaw advancement helps, and it might reduce snoring in the meantime.

3. Move to a custom EMA device. The Myerson EMA and other FDA-approved mandibular advancement devices (MADs) are designed to treat sleep apnea. They move the lower jaw forward and open the bite using elastic straps, allowing side-to-side movement. These are custom-made and adjusted by a dental sleep team, as recommended by the 2015 guidelines. "Custom" doesn't always mean a long wait; a dentist can make one during a visit using a vacuum-forming unit and the patient's own impression. This is a professionally fitted device for sleep apnea, not a simple boil-and-bite kit. It's useful for patients who need something quickly or if a device is lost or broken. While the EMA is commonly used, other FDA-approved custom devices are available. Panthera is 3D-printed with a rod system, and SomnoDent offers custom devices, including a Herbst-style model for snoring and mild-to-moderate sleep apnea. All these devices are custom-fitted, adjustable, and approved for sleep apnea, not just snoring.

4. Prove it. HSAT retest at 8–12 weeks with the physician. The custom EMA is the appliance Part 1 kept pointing toward; the OTC device is the on-ramp to it, never the destination.

Clinical Corner: The OTC-to-Custom On-Ramp

Your take-home this week: the device pathway on one page.

📎 Take-home #2: the OTC device trial consent form. Putting a snoring-cleared device in the mouth of a diagnosed OSA patient is exactly the moment to document expectations. We built a brandable patient consent/expectations form for the OTC trial. It states plainly that the device is not an OSA treatment, sets the retest rule, and records the plan to transition to a custom appliance.

One Question

Do you ever use an OTC device as a trial of tolerance before a custom appliance? Let’s share, elevate the profession as a whole, and improve lives. Hit reply and tell me how you play it.

A note on this issue's sponsor

Here's the clinical bridge to this issue's sponsor: a mandibular device works better through a clear nose. Nasal obstruction and mouth-breathing undercut how well any oral appliance is tolerated and how well it works. A patient fighting a blocked nose all night also fights the device. Which is where Xlear fits: a xylitol-based saline nasal care line, natural and drug-free, that keeps the nasal passage clean and patent so the appliance gets a fair shot. Made in American Fork, Utah, since 2000, it's the same "clear and hydrate" step from Part 1, now doing double duty for device tolerance.

Coach Cathy's Take

The device only works when used consistently, which is where many appliance stories fail—not due to a bad device, but because it's forgotten in a drawer. The first week is crucial. Mild morning jaw soreness is normal and usually subsides, but patients should be advised not to quit prematurely. Set expectations: initial tightness, gentle jaw movement upon waking, then easing. Involve the bed partner, as they notice quieter snoring, and their encouragement is invaluable.

Clarify that feeling rested isn't the same as being treated. Patients who feel good on an OTC device might skip the custom appliance and re-test. Celebrate comfort but insist on proof. Build habits through small wins, keep the device accessible, tie it to a nightly routine, and give it two weeks before judging its effectiveness.

Next week: Part 3

The nose is open, the device is in, and the custom appliance is on the way, but there's one more low-cost tool your patient can literally build. Part 3 takes on the homemade didgeridoo: airway and myofunctional training you can construct from household materials, and the surprising evidence behind it. See you then.

References

1. Ramar K, Dort LC, Katz SG, Lettieri CJ, Harrod CG, Thomas SM, Chervin RD. Clinical practice guideline for the treatment of obstructive sleep apnea and snoring with oral appliance therapy: an update for 2015. J Clin Sleep Med. 2015;11(7):773–827. doi: 10.5664/jcsm.4858. PMID: 26094920.

2. Vanderveken OM, Devolder A, Marklund M, et al. Comparison of a custom-made and a thermoplastic oral appliance for the treatment of mild sleep apnea. Am J Respir Crit Care Med. 2008;178(2):197–202. doi: 10.1164/rccm.200701-114OC. PMID: 17673699.

3. Somnofit-S/SnoreLessNow Anti-Snore Mouth Guard+ efficacy data (small, manufacturer-associated cohort), Sleep Science. Cited for context only; the device's FDA clearance is for snoring, not OSA.

4. U.S. Food and Drug Administration. 510(k) Premarket Notification K182312, Zyppah Inc., Zyppah Anti-Snoring Device. Cleared January 24, 2019. Indicated to reduce snoring in adults; labeling states the device does not treat obstructive sleep apnea.

5. U.S. Food and Drug Administration. 510(k) Premarket Notification K130558, SomnoMed, SomnoDent Herbst. Cleared May 17, 2013. Indicated for nighttime snoring and mild to moderate obstructive sleep apnea in patients 18 years and older; patient-specific, with an adjustable titration mechanism.

6. Panthera Dental. Panthera D-SAD product literature: custom-fitted, 3D-printed, medical-grade nylon oral appliance with a 0.5 mm increment titration system, indicated for snoring and/or obstructive sleep apnea.

Until next week,

Dr. Michael & Cathy Bennett
More Than Teeth | A Mission for Generational Health